Process Development Segment, by Services to Account the Largest Share in Cell and Gene Therapy Market during 2023-2031

According to our new research study on "Cell And Gene Therapy Market Forecast to 2031 - Global Analysis - by Type, Services, Scale, Service Provider, and End User," the market is expected to grow from US$ 4,485.00 million in 2023 to US$ 28,050.39 million by 2031; it is anticipated to record a CAGR of 25.8% from 2023 to 2031. The cell and gene therapy market report emphasizes trends prevalent in the global market, along with drivers and deterrents affecting its growth.

Automation of Cell and Gene Therapy Manufacturing Services Acts as a Trend of Cell And Gene Therapy Market Growth

Incorporating automation in cell and gene therapy manufacturing can lead to a reduced risk of contamination, improved consistency, and decreased cost of production. Lonza Cocoon and the CliniMACS Prodigy system from Miltenyi are a few of the devices designed to boost the automation of most sequential unit operations for a CAR-T process within a single system. With the rise in demand for cell and gene therapies, the production of cell and gene therapy products has shifted from a small-volume process to a large-volume process worldwide. In addition to the increasing research activities, the evolution of cell and gene therapy from an academic and clinical setting to commercialization has propelled the demand for automation in commercial manufacturing.

In May 2024, Ori Biotech launched IRO platform, an automated manufacturing platform. It's a piece of manufacturing tech designed to be space- and cost-efficient. The company says its tech is flexible enough to transition between projects at various stages of development. Further, government agencies are adopting automation in the manufacturing of cell therapies to increase national production capabilities. For instance, as of March 2023, the UK Stem Cell Bank of the Medicines and Healthcare Products Regulatory Agency (MHRA) was testing automated robotic technology for developing stem cell technology for the manufacturing of stem cell-based therapies. Thus, automation of cell and gene therapy manufacturing services is expected to bring new trends in the cell and gene therapy market in the coming years.

The cell and gene therapy market, by type, the cell and gene therapy market is segmented into bifurcated into cell therapy, gene therapy. The cell therapy segment held a larger market share in 2023.

The cell and gene therapy market, by services, the market is segmented into process development, cGMP manufacturing, regulatory services, bioassay services. The process development segment held a larger share of the market in 2023.

The cell and gene therapy market, by scale, the market is bifurcated into pre commercial/R and D manufacturing, commercial scale manufacturing. The pre commercial/R and D manufacturing segment held a larger share of the market in 2023.

The cell and gene therapy market, by service provider, the market is divided into CDMOs, CMOs. The CDMOs segment held a larger share of the market in 2023.

The cell and gene therapy market, by end user, the market is segmented into contract research organizations, pharmaceutical and biopharmaceutical companies, academic and research institutes. The pharmaceutical and biopharmaceutical companies segment dominated the market in 2023.

Thermo Fisher Scientific, Inc., Merck KGaA, Charles River Laboratories, Cell and Gene Therapy Catapult, Lonza, WuXi AppTec, Takara Bio Inc., Bristol Myers Squibb, FUJIFILM Holdings Corporation, F. Hoffmann-La Roche Ltd., and Catalent Biologics are among the leading companies operating in the global arterial blood gas kits market.

Companies operating in the cell and gene therapy market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the arterial blood gas kits market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall cell and gene therapy market growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com